New phase 1 data show potential for neurodegenerative disease treatment
Metabolic syndrome linked to faster brain ageing
Bowel cancer samples could boost understanding of other killer diseases
FDA clearance for non-muscle invasive bladder cancer treatment
AI+CRISPR=Precise gene editing
AXA signs agreement with Hainan Boao Lecheng Administration
ProBio launches AAV manufacturing service
Altasciences and VoxCell BioInnovation to collaborate on preclinical drug development
KAIST develops AI that automatically designs optimal drug candidates for cancer-targeting mutations
MetaVia collaborating with Syntekabio to boost drug options
Base to Base biotech podcast 21: Elix drug discovery platform and CytoAgents on CAR-T, CRS and the FDA
Ofichem expands capabilities with Swedish site acquisition